AI changes the evidence pattern, not the need for control.
FDA QMSRAI in QMS tools
AI-enabled eQMS, complaint triage, CAPA assistance, or supplier analytics should be controlled as quality-system software where applicable.
Design controls
AI-enabled device products still need design and risk evidence under device QMS expectations.
Supplier AI
Cloud and AI vendors should appear in supplier controls and quality agreements where they influence regulated work.
Management review
AI-related quality metrics should be visible when they affect the QMS.
AI governance must connect to existing regulated systems.
not isolatedQMSR transition plan
Connect this evidence to QMS, clinical, software, supplier, data, or lifecycle governance where applicable.
ISO 13485 gap assessment
Connect this evidence to QMS, clinical, software, supplier, data, or lifecycle governance where applicable.
Procedure update register
Connect this evidence to QMS, clinical, software, supplier, data, or lifecycle governance where applicable.
Training completion record
Connect this evidence to QMS, clinical, software, supplier, data, or lifecycle governance where applicable.
Design control evidence index
Connect this evidence to QMS, clinical, software, supplier, data, or lifecycle governance where applicable.
Risk management file crosswalk
Connect this evidence to QMS, clinical, software, supplier, data, or lifecycle governance where applicable.
Current public sources for FDA QMSR.
official firstThese links are the public source anchors for this workspace. Interpretation, checklists, and future assets should point back here before being reused outside iFeed.
FDA Quality Management System Regulation page
Current · FDA source page for QMSR background and implementation information.
Federal Register final rule
2024-02-02 · Final rule amending device quality-system requirements; effective date 2026-02-02.
21 CFR Part 820
Current · Current codified regulation text for Part 820 source checks.